ECSP099573A - Derivados heterocíclicos como receptores muscarínicos m3 - Google Patents
Derivados heterocíclicos como receptores muscarínicos m3Info
- Publication number
- ECSP099573A ECSP099573A EC2009009573A ECSP099573A ECSP099573A EC SP099573 A ECSP099573 A EC SP099573A EC 2009009573 A EC2009009573 A EC 2009009573A EC SP099573 A ECSP099573 A EC SP099573A EC SP099573 A ECSP099573 A EC SP099573A
- Authority
- EC
- Ecuador
- Prior art keywords
- muscarinic receptors
- heterocyclic derivatives
- heterocyclic
- derivatives
- antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Otolaryngology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Abstract
Esta invención se relaciona con antagonistas M3 de la fórmula (I): donde R2, R4, R5, R6, W, V, A, D, X, t, u y v son como se definió aquí; las composiciones farmacéuticas que los contienen los métodos para su preparación; y su uso en el tratamiento de enfermedades donde la activación del receptor M3 reforzada está implicada.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0702994A GB0702994D0 (en) | 2007-02-15 | 2007-02-15 | Compound and thier use |
GB0722678A GB0722678D0 (en) | 2007-11-19 | 2007-11-19 | Compounds and their use II |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP099573A true ECSP099573A (es) | 2009-12-28 |
Family
ID=39323641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2009009573A ECSP099573A (es) | 2007-02-15 | 2009-08-12 | Derivados heterocíclicos como receptores muscarínicos m3 |
Country Status (21)
Country | Link |
---|---|
US (1) | US20100056565A1 (es) |
EP (1) | EP2121688A1 (es) |
JP (1) | JP2010519193A (es) |
KR (1) | KR20090110353A (es) |
CN (1) | CN101657452A (es) |
AR (1) | AR065344A1 (es) |
AU (1) | AU2008215924B2 (es) |
BR (1) | BRPI0807913A2 (es) |
CA (1) | CA2676581A1 (es) |
CL (1) | CL2008000474A1 (es) |
CO (1) | CO6190612A2 (es) |
EC (1) | ECSP099573A (es) |
IL (1) | IL199971A0 (es) |
MX (1) | MX2009008323A (es) |
NZ (1) | NZ578489A (es) |
PE (1) | PE20090357A1 (es) |
RU (1) | RU2009133258A (es) |
SA (1) | SA08290066B1 (es) |
TW (1) | TW200843759A (es) |
UY (1) | UY30916A1 (es) |
WO (1) | WO2008099186A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200825084A (en) | 2006-11-14 | 2008-06-16 | Astrazeneca Ab | New compounds 521 |
WO2009098453A1 (en) * | 2008-02-06 | 2009-08-13 | Astrazeneca Ab | Azonia bicycloalkanes as m3 muscarinic acetylcholin receptor antagonists |
CA2723981A1 (en) | 2008-05-13 | 2009-11-19 | Astrazeneca Ab | New compounds 273 |
MX2011001577A (es) * | 2008-08-12 | 2011-05-02 | Pulmagen Therapeutics Synergy | Sal de 2-hidroxi-etansulfonato. |
WO2010018352A1 (en) * | 2008-08-12 | 2010-02-18 | Argenta Discovery Limited | Heterocyclic compounds used in the treatment of diseases where enhanced m3 receptor activation is implicated |
GB0814729D0 (en) * | 2008-08-12 | 2008-09-17 | Argenta Discovery Ltd | New combination |
GB0814728D0 (en) * | 2008-08-12 | 2008-09-17 | Argenta Discovery Ltd | New combination |
TW201036957A (en) | 2009-02-20 | 2010-10-16 | Astrazeneca Ab | Novel salt 628 |
CN104418851A (zh) * | 2013-09-02 | 2015-03-18 | 上海龙翔生物医药开发有限公司 | 奎宁环衍生物的制备方法及纯化方法 |
KR20170042608A (ko) * | 2014-08-26 | 2017-04-19 | 아스텔라스세이야쿠 가부시키가이샤 | 2-아미노티아졸 유도체 또는 그의 염 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8334494D0 (en) * | 1983-12-24 | 1984-02-01 | Tanabe Seiyaku Co | Carbostyril derivatives |
NZ225999A (en) * | 1987-09-10 | 1992-04-28 | Merck Sharp & Dohme | Azacyclic- or azabicyclic-substituted thiadiazole derivatives and pharmaceutical compositions |
IL88846A0 (en) * | 1988-01-08 | 1989-07-31 | Merck Sharp & Dohme | Lipophilic oxadiazoles,their preparation and pharmaceutical compositions containing them |
GB9603755D0 (en) * | 1996-02-22 | 1996-04-24 | Pfizer Ltd | Therapeutic agents |
DE19856475A1 (de) * | 1998-11-27 | 2000-05-31 | Schering Ag | Nichtsteroidale Entzündungshemmer |
US20020052312A1 (en) * | 2000-05-30 | 2002-05-02 | Reiss Theodore F. | Combination therapy of chronic obstructive pulmonary disease using muscarinic receptor antagonists |
ES2266291T3 (es) * | 2000-12-28 | 2007-03-01 | Almirall Prodesfarma Ag | Nuevos derivados de quinuclidina y composiciones medicinales que los contienen. |
PL375025A1 (en) * | 2002-09-30 | 2005-11-14 | Neurosearch A/S | Novel 1,4-diazabicycloalkane derivatives, their preparation and use |
BR0314183A (pt) * | 2002-09-30 | 2005-08-09 | Neurosearch As | Derivados de 1,4-diazabicicloalcano, quaisquer de seus enanciÈmeros ou qualquer mistura de seus enaciÈmeros, ou um seu sal de adição farmaceuticamente aceitável ou um seu n-óxido, composição farmacêutica, uso do dito composto, de qualquer um de seus enanciÈmeros ou de qualquer mistura de seus enanciÈmeros, ou de um seu sal de adição farmaceuticamente aceitável, e, método de tratamento, prevenção ou alìvio de uma doença ou um distúrbio ou condição de um corpo animal vivo |
US7056916B2 (en) * | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
ES2239546B1 (es) * | 2004-03-15 | 2006-12-01 | Almirall Prodesfarma, S.A. | Nuevos esteres de quinuclidina cuaternizados. |
GB0516313D0 (en) * | 2005-08-08 | 2005-09-14 | Argenta Discovery Ltd | Azole derivatives and their uses |
-
2008
- 2008-02-14 UY UY30916A patent/UY30916A1/es not_active Application Discontinuation
- 2008-02-14 AU AU2008215924A patent/AU2008215924B2/en not_active Ceased
- 2008-02-14 NZ NZ578489A patent/NZ578489A/en not_active IP Right Cessation
- 2008-02-14 CA CA002676581A patent/CA2676581A1/en not_active Abandoned
- 2008-02-14 BR BRPI0807913-7A2A patent/BRPI0807913A2/pt not_active IP Right Cessation
- 2008-02-14 TW TW097105181A patent/TW200843759A/zh unknown
- 2008-02-14 WO PCT/GB2008/000519 patent/WO2008099186A1/en active Application Filing
- 2008-02-14 KR KR1020097017018A patent/KR20090110353A/ko not_active Application Discontinuation
- 2008-02-14 CN CN200880012083A patent/CN101657452A/zh active Pending
- 2008-02-14 AR ARP080100627A patent/AR065344A1/es unknown
- 2008-02-14 RU RU2009133258/04A patent/RU2009133258A/ru not_active Application Discontinuation
- 2008-02-14 CL CL200800474A patent/CL2008000474A1/es unknown
- 2008-02-14 EP EP08709410A patent/EP2121688A1/en not_active Withdrawn
- 2008-02-14 JP JP2009549470A patent/JP2010519193A/ja active Pending
- 2008-02-14 PE PE2008000323A patent/PE20090357A1/es not_active Application Discontinuation
- 2008-02-14 MX MX2009008323A patent/MX2009008323A/es active IP Right Grant
- 2008-02-14 US US12/523,609 patent/US20100056565A1/en not_active Abandoned
- 2008-02-16 SA SA08290066A patent/SA08290066B1/ar unknown
-
2009
- 2009-07-20 IL IL199971A patent/IL199971A0/en unknown
- 2009-07-28 CO CO09078490A patent/CO6190612A2/es not_active Application Discontinuation
- 2009-08-12 EC EC2009009573A patent/ECSP099573A/es unknown
Also Published As
Publication number | Publication date |
---|---|
NZ578489A (en) | 2011-05-27 |
MX2009008323A (es) | 2009-08-13 |
SA08290066B1 (ar) | 2011-05-14 |
UY30916A1 (es) | 2008-09-30 |
WO2008099186A8 (en) | 2008-11-13 |
AR065344A1 (es) | 2009-06-03 |
WO2008099186A1 (en) | 2008-08-21 |
EP2121688A1 (en) | 2009-11-25 |
IL199971A0 (en) | 2010-04-15 |
JP2010519193A (ja) | 2010-06-03 |
AU2008215924B2 (en) | 2011-04-21 |
AU2008215924A1 (en) | 2008-08-21 |
US20100056565A1 (en) | 2010-03-04 |
CN101657452A (zh) | 2010-02-24 |
CA2676581A1 (en) | 2008-08-21 |
RU2009133258A (ru) | 2011-03-20 |
KR20090110353A (ko) | 2009-10-21 |
CL2008000474A1 (es) | 2008-08-22 |
CO6190612A2 (es) | 2010-08-19 |
TW200843759A (en) | 2008-11-16 |
BRPI0807913A2 (pt) | 2014-06-17 |
PE20090357A1 (es) | 2009-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP099573A (es) | Derivados heterocíclicos como receptores muscarínicos m3 | |
UY31124A1 (es) | Derivados de oxiadazol y su uso como potenciadores del receptor metabotropico de glutamato - 842 | |
ECSP066856A (es) | Compuestos novedosos como moduladores del receptor opioide | |
CR10545A (es) | Prolinamida-2-5-oxo fenilmetil-n-sustituidos como receptores antagonistas y sus metodos de uso | |
CR10236A (es) | Modulares del indol sulfonamida de receptores de progesterona | |
ECSP067121A (es) | 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas | |
SV2006002098A (es) | Compuestos de morfolina sustituida para el tratamiento de trastornos del sistema nervioso central ref. pc32250a | |
UY29798A1 (es) | Derivados de carboxamida como antagonistas del receptor muscarínico | |
CR10922A (es) | Derivados de indol como antagonistas receptores de s1p1 | |
UY29267A1 (es) | Derivados de piperidina y su uso como agentes antiinflamatorios | |
CL2008001946A1 (es) | Compuestos derivados de imidazol, antagonistas de receptores ccr2, ccr3, ccr5; procedimiento de preparacion; y uso en el tratamiento de enfermedades vasculares perifericas. | |
ECSP099394A (es) | Derivados de quinuclidinol como antogonistas de receptores muscarínicos | |
ECSP099370A (es) | Derivados de hidantoína usados como inhibidores de mmp | |
HN2010001563A (es) | Compuestos | |
CR10243A (es) | "bencimidazoles 2-sustituidos como modulares de receptor de androgeno selectivos" | |
CL2011000917A1 (es) | Compuestos derivados de tioamida; sus metodos de preparacion y uso de los compuestos para el tratamiento de enfermedades endoparasitarias. | |
CR10489A (es) | Derivados fenil-pirazol como ligandos de receptores glucocorticoides no esteroides | |
NI201000090A (es) | Agonistas novedosos de los receptores de glucocorticoides. | |
AR060536A1 (es) | Agonista del receptor de glucocorticoides y composiciones farmaceuticas | |
UY30052A1 (es) | 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas | |
CR8775A (es) | 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas | |
UY30534A1 (es) | Derivados de 5,6-bisaril-2-piridin-carboxamida, su preparacion y su aplicacion en terapéutica como antagonistas de los receptores de urotensina ii | |
ECSP099425A (es) | Derivados de amina y su uso en enfermedades mediadas por el adrenorecetor beta 2 | |
CO6351723A2 (es) | Derivados de pirazolo-[5,1-b]-oxazol como antagonistas de crf1 | |
CO6300937A2 (es) | Derivados de 3-carboxipropil-aminotetralina y compuestos relacionados como antagonistas de receptores opioides mu |